|
US4327725A
(en)
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
|
US4624848A
(en)
|
1984-05-10 |
1986-11-25 |
Ciba-Geigy Corporation |
Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
|
|
US4739044A
(en)
|
1985-06-13 |
1988-04-19 |
Amgen |
Method for derivitization of polynucleotides
|
|
US4757141A
(en)
|
1985-08-26 |
1988-07-12 |
Applied Biosystems, Incorporated |
Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
|
|
US4968509A
(en)
|
1987-07-27 |
1990-11-06 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
|
IT1222414B
(it)
|
1987-07-31 |
1990-09-05 |
Chiesi Farma Spa |
Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
|
|
US4843155A
(en)
|
1987-11-19 |
1989-06-27 |
Piotr Chomczynski |
Product and process for isolating RNA
|
|
IL92966A
(en)
|
1989-01-12 |
1995-07-31 |
Pfizer |
Dispensing devices powered by hydrogel
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
|
US6040138A
(en)
|
1995-09-15 |
2000-03-21 |
Affymetrix, Inc. |
Expression monitoring by hybridization to high density oligonucleotide arrays
|
|
US5800992A
(en)
|
1989-06-07 |
1998-09-01 |
Fodor; Stephen P.A. |
Method of detecting nucleic acids
|
|
WO1992018106A1
(fr)
|
1991-04-16 |
1992-10-29 |
Nippon Shinyaku Co., Ltd. |
Procede de production d'une dispersion solide
|
|
US5994056A
(en)
|
1991-05-02 |
1999-11-30 |
Roche Molecular Systems, Inc. |
Homogeneous methods for nucleic acid amplification and detection
|
|
US5770358A
(en)
|
1991-09-18 |
1998-06-23 |
Affymax Technologies N.V. |
Tagged synthetic oligomer libraries
|
|
JP3195391B2
(ja)
|
1991-11-14 |
2001-08-06 |
エスエス製薬株式会社 |
徐放性トラピジル錠
|
|
HU227530B1
(en)
|
1991-11-22 |
2011-07-28 |
Warner Chilcott Company |
Delayed-release compositions containing risedronate and process for their production
|
|
US5384261A
(en)
|
1991-11-22 |
1995-01-24 |
Affymax Technologies N.V. |
Very large scale immobilized polymer synthesis using mechanically directed flow paths
|
|
CA2124087C
(en)
|
1991-11-22 |
2002-10-01 |
James L. Winkler |
Combinatorial strategies for polymer synthesis
|
|
US6033854A
(en)
|
1991-12-16 |
2000-03-07 |
Biotronics Corporation |
Quantitative PCR using blocking oligonucleotides
|
|
US5348853A
(en)
|
1991-12-16 |
1994-09-20 |
Biotronics Corporation |
Method for reducing non-specific priming in DNA amplification
|
|
US5567583A
(en)
|
1991-12-16 |
1996-10-22 |
Biotronics Corporation |
Methods for reducing non-specific priming in DNA detection
|
|
US5461140A
(en)
|
1992-04-30 |
1995-10-24 |
Pharmaceutical Delivery Systems |
Bioerodible polymers for solid controlled release pharmaceutical compositions
|
|
IT1255522B
(it)
|
1992-09-24 |
1995-11-09 |
Ubaldo Conte |
Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
|
|
JP2616252B2
(ja)
|
1992-10-16 |
1997-06-04 |
日本新薬株式会社 |
ワックスマトリックスの製法
|
|
US5686105A
(en)
|
1993-10-19 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
ES2293638T3
(es)
*
|
1994-03-25 |
2008-03-16 |
Isotechnika, Inc. |
Mejora de la eficacia de farmacos por deuteracion.
|
|
US5556752A
(en)
|
1994-10-24 |
1996-09-17 |
Affymetrix, Inc. |
Surface-bound, unimolecular, double-stranded DNA
|
|
DE19514048A1
(de)
|
1995-04-13 |
1996-10-17 |
Rentschler Arzneimittel |
Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern
|
|
JPH11505258A
(ja)
|
1995-05-17 |
1999-05-18 |
セダーシナイ メディカル センター |
小腸における消化および吸収を改善させる脂肪酸を含む組成物
|
|
US5545531A
(en)
|
1995-06-07 |
1996-08-13 |
Affymax Technologies N.V. |
Methods for making a device for concurrently processing multiple biological chip assays
|
|
US5854033A
(en)
|
1995-11-21 |
1998-12-29 |
Yale University |
Rolling circle replication reporter systems
|
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
|
EP0880598A4
(en)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US5869717A
(en)
|
1997-09-17 |
1999-02-09 |
Uop Llc |
Process for inhibiting the polymerization of vinyl aromatics
|
|
DE69829402T2
(de)
|
1997-10-31 |
2006-04-13 |
Affymetrix, Inc. (a Delaware Corp.), Santa Clara |
Expressionsprofile in adulten und fötalen organen
|
|
US6020135A
(en)
|
1998-03-27 |
2000-02-01 |
Affymetrix, Inc. |
P53-regulated genes
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
JP2001322933A
(ja)
|
2000-05-15 |
2001-11-20 |
Ucb Sa |
Ｃｄ４０シグナル遮断剤
|
|
US6465014B1
(en)
|
2001-03-21 |
2002-10-15 |
Isp Investments Inc. |
pH-dependent sustained release, drug-delivery composition
|
|
US6960563B2
(en)
|
2001-08-31 |
2005-11-01 |
Morton Grove Pharmaceuticals, Inc. |
Spontaneous emulsions containing cyclosporine
|
|
WO2005007096A2
(en)
|
2003-07-11 |
2005-01-27 |
Merck & Co., Inc. |
Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator
|
|
US20080242657A1
(en)
|
2004-03-26 |
2008-10-02 |
Marino Michael J |
Treatment of Tremor with Histamine H3 Inverse Agonists or Hist Amine H3 Antagonists
|
|
CN101360421B
(zh)
|
2005-11-18 |
2014-06-18 |
康乃尔研究基金会有限公司 |
烟酰核苷组合物及其使用方法
|
|
KR20100019470A
(ko)
*
|
2007-04-30 |
2010-02-18 |
아보트 러보러터리즈 |
디아실글리세롤 ｏ-아실트랜스퍼라제 타입 １ 효소의 억제제
|
|
WO2009070805A2
(en)
|
2007-12-01 |
2009-06-04 |
Asuragen, Inc. |
Mir-124 regulated genes and pathways as targets for therapeutic intervention
|
|
WO2009129537A2
(en)
|
2008-04-18 |
2009-10-22 |
Gary Zabow |
Magnetic microstructures for magnetic resonance imaging
|
|
KR102759126B1
(ko)
|
2010-12-30 |
2025-01-24 |
파운데이션 메디신 인코포레이티드 |
종양 샘플의 다유전자 분석의 최적화
|
|
US20140045856A1
(en)
|
2012-07-31 |
2014-02-13 |
Boehringer Ingelheim International Gmbh |
4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
|
|
KR101534395B1
(ko)
|
2013-08-01 |
2015-07-09 |
서울대학교산학협력단 |
트라피딜을 유효성분으로 포함하는 골 관련 질환의 예방 또는 치료용 조성물
|
|
WO2017059118A1
(en)
|
2015-09-29 |
2017-04-06 |
Duke University |
Compositions and methods for identifying and treating dystonia disorders
|
|
US11281170B2
(en)
|
2015-12-29 |
2022-03-22 |
Jones And Malterer Technology Innovations Incorporated |
Multi-point synchronizable and scalable lighting control systems
|
|
JP7049683B2
(ja)
*
|
2016-04-04 |
2022-04-07 |
シノピア バイオサイエンシーズ，インク． |
トラピジルを使用する錐体外路症候群の処置
|
|
MX2020007994A
(es)
*
|
2018-02-02 |
2020-09-09 |
Boehringer Ingelheim Int |
Derivados de triazolopirimidina para usar como inhibidores de ghrelin o-aciltransferasa (goat).
|
|
CA3163242A1
(en)
|
2019-12-02 |
2021-06-10 |
Aarash BORDBAR |
Treating cognitive disorders using trapidil
|
|
MX2022011879A
(es)
|
2020-03-26 |
2023-01-11 |
Sinopia Biosciences Inc |
Derivados de trapidilo marcados isotopicamente.
|
|
US20230242538A1
(en)
|
2020-06-24 |
2023-08-03 |
Yale University |
PanK Modulators and Methods Using Same
|